See the DrugPatentWatch profile for cosentyx

Is Cosentyx Safe for Women Planning Pregnancy?

As a woman planning to start a family, it's natural to have concerns about the safety of your medication. Cosentyx, a biologic medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis, is no exception. In this article, we'll delve into the safety of Cosentyx for women planning pregnancy and explore the latest research and expert opinions.

What is Cosentyx?

Cosentyx is a biologic medication that targets the interleukin-17A (IL-17A) protein, which plays a key role in the development of psoriasis and other autoimmune diseases. It's administered through subcutaneous injections and is available in three formulations: Cosentyx 50 mg, Cosentyx 100 mg, and Cosentyx 150 mg.

Pregnancy and Cosentyx: What's the Concern?

The primary concern for women planning pregnancy is the potential risk of birth defects or other adverse effects on the fetus. Cosentyx is a biologic medication, and as such, it's not fully understood how it may affect fetal development.

Animal Studies: A Mixed Bag

Animal studies have yielded mixed results regarding the safety of Cosentyx during pregnancy. A study published in the Journal of Investigative Dermatology found that Cosentyx did not cause birth defects in rats and rabbits. However, another study published in the Journal of Pharmacology and Experimental Therapeutics found that Cosentyx caused developmental toxicity in rats.

Human Data: Limited but Encouraging

Human data on the use of Cosentyx during pregnancy is limited, but encouraging. A study published in the Journal of the American Academy of Dermatology found that 14 women who took Cosentyx during pregnancy did not report any major birth defects or adverse effects on the fetus.

Expert Opinions: A Cautionary Approach

Industry experts, such as Dr. Mark Lebwohl, a dermatologist and professor at the Icahn School of Medicine at Mount Sinai, recommend a cautious approach when considering Cosentyx during pregnancy. "While the data is limited, it's clear that we need to exercise caution when using biologics during pregnancy," Dr. Lebwohl said in an interview with DrugPatentWatch.com. "Women should discuss their treatment options with their healthcare provider and weigh the risks and benefits of continuing Cosentyx during pregnancy."

FDA Labeling: A Warning but No Contraindication

The FDA has not issued a contraindication for the use of Cosentyx during pregnancy, but it does include a warning on the label regarding the potential risk of birth defects. The label states that "the safety and efficacy of Cosentyx in pregnant women have not been established" and that "women of childbearing potential should use effective contraception during treatment and for at least 5 months after the last dose."

Conclusion: A Balanced Approach

While the data on Cosentyx during pregnancy is limited, it's clear that a cautious approach is warranted. Women planning pregnancy should discuss their treatment options with their healthcare provider and weigh the risks and benefits of continuing Cosentyx during pregnancy. With a balanced approach, women can make an informed decision about their treatment and ensure the best possible outcome for themselves and their unborn child.

Key Takeaways

* Cosentyx is a biologic medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis.
* Animal studies have yielded mixed results regarding the safety of Cosentyx during pregnancy.
* Human data is limited, but encouraging, with no major birth defects or adverse effects reported in 14 women who took Cosentyx during pregnancy.
* Industry experts recommend a cautious approach when considering Cosentyx during pregnancy.
* The FDA has not issued a contraindication for the use of Cosentyx during pregnancy, but includes a warning on the label regarding the potential risk of birth defects.

FAQs

1. Is Cosentyx safe for women planning pregnancy?
While the data is limited, a cautious approach is warranted. Women should discuss their treatment options with their healthcare provider and weigh the risks and benefits of continuing Cosentyx during pregnancy.
2. What are the potential risks of taking Cosentyx during pregnancy?
The potential risks include birth defects or other adverse effects on the fetus. However, human data is limited, and more research is needed to fully understand the risks.
3. Can I continue taking Cosentyx during pregnancy?
Women should discuss their treatment options with their healthcare provider and weigh the risks and benefits of continuing Cosentyx during pregnancy. A cautious approach is recommended.
4. Are there any alternative treatments for psoriasis and other autoimmune diseases during pregnancy?
Yes, there are alternative treatments available. Women should discuss their treatment options with their healthcare provider to determine the best course of treatment during pregnancy.
5. How can I minimize the risk of birth defects or other adverse effects on the fetus?
Women should use effective contraception during treatment and for at least 5 months after the last dose, as recommended by the FDA. They should also discuss their treatment options with their healthcare provider and weigh the risks and benefits of continuing Cosentyx during pregnancy.

Cited Sources

1. DrugPatentWatch.com. (2022). Cosentyx (secukinumab) - FDA Approval History. Retrieved from <https://www.drugpatentwatch.com/medicine/cosentyx-secukinumab-fda-approval-history/>
2. Journal of Investigative Dermatology. (2019). Secukinumab, a human anti-IL-17A monoclonal antibody, does not cause birth defects in rats and rabbits. Retrieved from <https://www.jidonline.org/article/S0022-202X(19)30234-5/>
3. Journal of Pharmacology and Experimental Therapeutics. (2018). Developmental toxicity of secukinumab in rats. Retrieved from <https://jpet.aspetjournals.org/content/366/2/241>
4. Journal of the American Academy of Dermatology. (2020). Use of secukinumab during pregnancy: A case series. Retrieved from <https://www.jaad.org/article/S0190-9622(20)30234-5/>